Skip to main content

Atossa Therapeutics, Inc.

ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001488039

No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Atossa Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+8 vs. Q1 2023
Shares held
16.0M
−342.3K (−2.1%) vs. Q1 2023
Total value
$20.2M
+$8.32M (+70.1%) vs. Q1 2023
New holders
11
10 more added
Sold out
3
14 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ATOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 52 institutions
Q1 2021: 54 institutionsQ2 2021: 90 institutionsQ3 2021: 93 institutionsQ4 2021: 92 institutionsQ1 2022: 83 institutionsQ2 2022: 73 institutionsQ3 2022: 59 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 52 institutionsQ3 2023: 54 institutionsQ4 2023: 49 institutionsQ1 2024: 67 institutionsQ2 2024: 77 institutionsQ3 2024: 86 institutionsQ4 2024: 86 institutionsQ1 2025: 83 institutionsQ2 2025: 84 institutionsQ3 2025: 67 institutionsQ4 2025: 67 institutionsQ1 2026: 33 institutionsQ2 2026: 31 institutions
Value heldQ2 2023: $20.2M
Q1 2021: $22.8MQ2 2021: $225.8MQ3 2021: $102.1MQ4 2021: $64.2MQ1 2022: $45.4MQ2 2022: $25.4MQ3 2022: $15.8MQ4 2022: $9.49MQ1 2023: $11.9MQ2 2023: $20.2MQ3 2023: $11.9MQ4 2023: $14.2MQ1 2024: $37.4MQ2 2024: $31.2MQ3 2024: $41.8MQ4 2024: $28.3MQ1 2025: $19.1MQ2 2025: $17.7MQ3 2025: $16.9MQ4 2025: $13.0MQ1 2026: $6.52MQ2 2026: $2.60M
Institutions holding ATOS and their total value by quarter
QuarterHoldersValue
Q2 202631$2.60M
Q1 202633$6.52M
Q4 202567$13.0M
Q3 202567$16.9M
Q2 202584$17.7M
Q1 202583$19.1M
Q4 202486$28.3M
Q3 202486$41.8M
Q2 202477$31.2M
Q1 202467$37.4M
Q4 202349$14.2M
Q3 202354$11.9M
Q2 202352$20.2M
Q1 202345$11.9M
Q4 202251$9.49M
Q3 202259$15.8M
Q2 202273$25.4M
Q1 202283$45.4M
Q4 202192$64.2M
Q3 202193$102.1M
Q2 202190$225.8M
Q1 202154$22.8M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Atossa Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding ATOS in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc5,675,724$7.15M0.00%−21,812−0.4%Reduced
BlackRock Inc.2,898,466$3.65M0.00%−306,065−9.6%Reduced
Laurion Capital Management LP2,225,800$2.80M0.12%00.0%Unchanged
Geode Capital Management, LLC1,112,612$1.40M0.00%−98,273−8.1%Reduced
Renaissance Technologies LLC1,074,070$1.35M0.00%+138,000+14.7%Added
State Street Corp436,271$549.7K0.00%−44,724−9.3%Reduced
Susquehanna International Group, LLP373,032$470.0K0.00%+267,390+253.1%Added
Millennium Management LLC316,405$398.7K0.00%−147,523−31.8%Reduced
Gsa Capital Partners LLP302,604$381.0K0.04%+302,604New
D. E. Shaw & Co., Inc.216,528$272.8K0.00%−606,834−73.7%Reduced
Northern Trust Corp214,642$270.4K0.00%−834−0.4%Reduced
Morgan Stanley195,891$246.8K0.00%+25,136+14.7%Added
Bank of New York Mellon Corp112,656$141.9K0.00%−38,624−25.5%Reduced
Mariner, LLC104,910$132.2K0.00%00.0%Unchanged
Virtu Financial LLC86,813$109.0K0.01%+86,813New
Jane Street Group, LLC78,871$99.4K0.00%+56,310+249.6%Added
Group One Trading, L.P.74,635$94.0K0.00%+10,607+16.6%Added
Two Sigma Investments, LP58,147$73.3K0.00%−6,100−9.5%Reduced
Edmond de Rothschild Holding S.A.50,000$63.0K0.00%00.0%Unchanged
LPL Financial LLC46,992$59.2K0.00%+46,992New
Charles Schwab Investment Management Inc45,962$57.9K0.00%00.0%Unchanged
XTX Topco Ltd39,383$49.6K0.01%+39,383New
Commonwealth Equity Services, LLC34,605$44.0K0.00%+50+0.1%Added
Two Sigma Advisers, LP27,400$34.5K0.00%−33,400−54.9%Reduced
Two Sigma Securities, LLC25,178$31.7K0.00%+25,178New
LVM Capital Management Ltd21,000$26.0K0.00%+21,000New
HighTower Advisors, LLC20,100$25.0K0.00%00.0%Unchanged
Wolverine Trading, LLC18,734$24.0K0.00%+18,734New
Tower Research Capital LLC (TRC)16,784$21.1K0.00%+6,384+61.4%Added
Advisor Group Holdings, Inc.15,247$19.2K0.00%−230−1.5%Reduced
Victory Capital Management Inc13,865$17.5K0.00%−321−2.3%Reduced
Cetera Advisor Networks LLC13,332$16.8K0.00%+2,900+27.8%Added
Federation des caisses Desjardins du Quebec12,600$15.9K0.00%00.0%Unchanged
J. L. Bainbridge & Co., Inc.10,621$13.4K0.00%00.0%Unchanged
Dark Forest Capital Management LP10,193$12.8K0.00%+10,193New
Baader Bank INC10,861$10.6K0.00%+10,861New
Wells Fargo & Company5,057$6.37K0.00%+34+0.7%Added
FMR LLC4,684$5.90K0.00%−26,524−85.0%Reduced
BNP Paribas Arbitrage, SA4,555$5.74K0.00%00.0%Unchanged
Bank of America Corp1,800$2.27K0.00%−2,530−58.4%Reduced
Harbour Investments, Inc.1,711$2.16K0.00%00.0%Unchanged
St. Johns Investment Management Company, LLC1,550$1.95K0.00%00.0%Unchanged
Allworth Financial LP702$8850.00%00.0%Unchanged
TD Waterhouse Canada Inc.700$8750.00%00.0%Unchanged
Castleview Partners, LLC500$6300.00%00.0%Unchanged
Citigroup Inc170$2140.00%+170New
Delos Wealth Advisors, LLC100$1260.00%00.0%Unchanged
JPMorgan Chase & Co94$1180.00%00.0%Unchanged
Clearstead Advisors, LLC70$890.00%+70New
Royal Bank of Canada173$00.00%+153+765.0%Added
Hantz Financial Services, Inc.82$00.00%00.0%Unchanged
Cutler Group LP574$00.00%00.0%Unchanged
Sabby Management, LLC0$00.00%−65,714−100.0%Sold out
Lincoln National Corp0$00.00%−10,340−100.0%Sold out
National Bank of Canada0$00.00%−1,400−100.0%Sold out
ETF Managers Group, LLC––––Not filed